Clinical Trial Update: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [Phase 1]

View source ↗

Summary

A Phase 1 study of flavopiridol in children with relapsed or refractory solid tumors or lymphomas has completed, focusing on safety and dosing in pediatric pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Cerebellar Astrocytoma
• Cerebral Astrocytoma
• Ependymoma
• Medulloblastoma
• Neuroblastoma
• Osteosarcoma
• Wilms Tumor

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma | Phase 1 | Status: COMPLETED